Steep discounts help biotech drug copies gain ground in Europe
September 23, 2015 at 10:14 AM EDT
LONDON, Sept 23 (Reuters) - Cut-price versions of expensive biotech drugs are gaining ground in Europe, following surprisingly steep price discounts offered on the first copy of a complex antibody medicine for rheumatoid arthritis and Crohn's disease.